Riskpilot← Back to searchSign inGet full accessISVIK HELSE AS
ASActiveOrg 989232967General medical practice activities · NACE 8621Est. 20066 employees
Revenue 2025
NOK 7M
0% vs 2024
EBITDA margin
27.7%
+6% vs 2024
Equity ratio
41.9%
Financial strength
Net profit 2025
NOK 807K
+21% vs 2024
| Revenue | NOK 7M | +0% |
| EBITDA | NOK 1,9M | +6% |
| Net profit | NOK 807K | +21% |
| Total assets | NOK 16,7M | -4% |
| Equity | NOK 7M | +6% |
| Employees | 6 | — |
Legal name
ISVIK HELSE AS
Org number
989232967
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. januar 2006
Share capital
NOK 2 900 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styreleiar åleine eller dagleg leiar åleine.
Company purpose
Legevirksomhet samt utleie av fast eiendom, samt hva hermed står i forbindelse, samt å delta i andre selskap med lignende virksomhet.
Address
Phone
+4793438664
Email
post@isvik.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 960 | 5 292 | 5 768 | 6 971 | 6 971 |
| Staff expenses | −1 726 | −1 808 | −2 021 | −2 969 | −2 707 |
| EBITDA | 3 825 | 1 863 | 2 144 | 1 825 | 1 930 |
| Depreciation & amort. | −553 | −610 | −608 | −611 | −627 |
| EBIT | 3 271 | 1 253 | 1 535 | 1 213 | 1 302 |
| Net financials | −285 | −260 | −361 | −361 | −269 |
| Profit before tax | 2 987 | 993 | 1 175 | 852 | 1 034 |
| Tax | 657 | 219 | 259 | 188 | 227 |
| Net profit | 2 330 | 774 | 916 | 664 | 807 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 14 538 | 13 461 | 13 403 | 17 435 | 16 738 |
| Equity | 4 588 | 5 362 | 6 278 | 6 642 | 7 009 |
| Long-term debt | 8 247 | 7 184 | 6 131 | 9 395 | 0 |
| Short-term debt | 1 703 | 915 | 995 | 1 398 | 1 563 |
| Total debt | 9 950 | 8 099 | 7 125 | 10 793 | 9 730 |
EBITDA margin
27.7%
This company
15.8%
Market median
+75% vs market
20212025
Equity ratio
41.9%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20212025
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20212025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TE Chief Executive Officer | Chief Executive Officer | 2006 |
AS Deputy Member | Deputy Member | 2006 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ISVIK HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Egil Kleiven | Chief Executive Officer | 0 companies |
| Anne Sinnes Kleiven | Deputy Member | 0 companies |